CompletedPhase 2NCT00453232
Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors
Studying Extragonadal germ cell tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Principal Investigator
- Michael Williams, MDCambridge University Hospitals NHS Foundation Trust
- Intervention
- bleomycin sulfate(biological)
- Enrollment
- 20 enrolled
- Eligibility
- 18-40 years · MALE
- Timeline
- 2004 – 2009
Study locations (7)
- Addenbrooke's Hospital, Cambridge, England, United Kingdom
- Leeds Cancer Centre at St. James's University Hospital, Leeds, England, United Kingdom
- Saint Bartholomew's Hospital, London, England, United Kingdom
- Northern Centre for Cancer Treatment at Newcastle General Hospital, Newcastle upon Tyne, England, United Kingdom
- Churchill Hospital, Oxford, England, United Kingdom
- Edinburgh Cancer Centre at Western General Hospital, Edinburgh, Scotland, United Kingdom
- Beatson West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00453232 on ClinicalTrials.govOther trials for Extragonadal germ cell tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06418789High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell TumorsN.N. Petrov National Medical Research Center of Oncology
- RECRUITINGPHASE3NCT03067181Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsChildren's Oncology Group
- ACTIVE NOT RECRUITINGPHASE3NCT02375204Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell TumorsAlliance for Clinical Trials in Oncology